Table 3.
Category | ALTn (P 25–P 75) | ASTn (P 25–P 75) | ALPn (P 25–P 75) | LDHn (P 25–P 75) |
---|---|---|---|---|
BMD | 2.91 (1.96–4.61) (↑) | 2.85 (1.76–4.5) (↑) | 1.06 ± 0.46 (→) | 2.02 (1.49–3.48) (↑) |
DMD | 6.55 (4.85–8.18) (↑) | 5.32 (3.98–6.68) (↑) | 1.1 (0.94–1.25) (↑) | 4.28 (3.23–5.60) (↑) |
EDMD | 0.50 (0.36–0.83) (→) | 0.73 (0.69–1.04) (→) | 1.15 ± 0.54 (→) | 1.06 ± 0.19 (→) |
FSHD | 1.04 ± 0.48 (→) | 1.00 (0.87–1.44) (→) | 0.60 (0.42–0.92) (→) | 1.02 (0.93–1.44) (→) |
LGMD | 1.65 (0.74–3.39) (↑) | 1.68 (1.01–2.86) (↑) | 0.55 (0.45–1.17) (→) | 1.49 (1.00–2.37) (↑) |
MD, muscular dystrophy; DMD, Duchenne muscular dystrophy; BMD, Becker's muscular dystrophy; FSHD, facioscapulohumeral dystrophy; LGMD, limb girdle muscular dystrophy; EDMD, Emery-Dreifuss muscular dystrophy; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; LDH, lactic dehydrogenase.
“→” represents that patients had similar levels of enzymes comparing with normal people (p > 0.05). “↑” represents that patients had significantly higher levels of enzymes comparing with normal people (p < 0.05).